BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Compounds/Olmesartan Medoxomil
✓ FULLY PROFILED

Olmesartan Medoxomil

300+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Olmesartan Medoxomil 2D molecular structure
PubMed Studies
300+
Targets
10
Pathways
10
Molecular Targets
AGTR1SLCO1B1SLCO1B3ABCB11ABCC2ABCC3ALBGPR151HOMOPDE4D

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways
INFLAMMATIONINSULIN_SIGNALINGCIRCADIANAPOPTOSISNITRIC_OXIDEGLUCOSE_METABOLISMSTEM_CELLSLIPID_METABOLISMOXIDATIVE_STRESSCOLLAGEN_ECM

Biological pathways associated with Olmesartan Medoxomil based on target analysis.

Biological Mechanisms
NF-κBNF-κBIRSInsulin SignalingNONitric OxideNRF2Nrf2

Biological mechanisms activated or modulated by Olmesartan Medoxomil based on pathway and target analysis.

Health Goals
Inflammation →Longevity →Energy →Sleep →Endurance →

Health goals where Olmesartan Medoxomil ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions
Chronic Inflammation →Arthritis →Type 2 Diabetes →Metabolic Syndrome →Insomnia →

Health conditions associated with the biological pathways influenced by Olmesartan Medoxomil.

External References
PubChem CID 130881 →300 PubMed studies →
Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Olmesartan Medoxomil →
Data Source
Corpusv20260307-01
PubMed studies300
PubChem CID130881
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Olmesartan Medoxomil is generated from 300 PubMed-indexed studies. Key molecular targets include AGTR1, SLCO1B1, SLCO1B3. Associated biological pathways: INFLAMMATION, INSULIN_SIGNALING, CIRCADIAN. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.